Hikaru Sasaki
Affiliations: | Neurosurgery | Keio University, Tokyo, Minato-ku, Tōkyō-to, Japan |
Area:
Chemotherapy, Brain TumorWebsite:
http://web.sc.itc.keio.ac.jp/ns/eng/ikyoku_eng/index_staff_eng.htmlGoogle:
"Hikaru Sasaki"Cross-listing: Neurotree - Neuropathology Tree
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sasaki H. (2023) [Meningioma]. No Shinkei Geka. Neurological Surgery. 51: 829-836 |
| Tamura R, Iwanami A, Ohara K, et al. (2023) Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence. Brain Tumor Pathology |
| Pareira ES, Shibuya M, Ohara K, et al. (2022) The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas. Brain Tumor Pathology. 39: 79-87 |
| Kanazawa T, Ohara K, Kitamura Y, et al. (2021) Histopathological investigation of the 1p/19q-codeleted gliomas resected following alkylating agent chemotherapy. Journal of Neuro-Oncology |
| Kumon M, Nakae S, Murayama K, et al. (2021) Myoinositol to Total Choline Ratio in Glioblastomas as a Potential Prognostic Factor in Preoperative Magnetic Resonance Spectroscopy. Neurologia Medico-Chirurgica |
| Arita H, Matsushita Y, Machida R, et al. (2020) TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations. Acta Neuropathologica Communications. 8: 201 |
| Kanazawa T, Minami Y, Takahashi H, et al. (2019) Magnetic resonance imaging texture analyses in lower-grade gliomas with a commercially available software: correlation of apparent diffusion coefficient and T2 skewness with 1p/19q codeletion. Neurosurgical Review |
| Kuwahara K, Ohba S, Nakae S, et al. (2019) Clinical, histopathological, and molecular analyses of IDH-wild-type WHO grade II-III gliomas to establish genetic predictors of poor prognosis. Brain Tumor Pathology |
| Pareira E, Ohara K, Shibuya M, et al. (2019) PATH-58. REAPPRAISAL OF HISTOLOGICAL FEATURES AND MOLECULAR ANALYSIS OF LOWER GRADE GLIOMAS AND ASSOCIATION WITH OVERALL SURVIVALS Neuro-Oncology. 21: vi156-vi156 |
| Arita H, Matsushita Y, Ohno M, et al. (2019) PATH-37. PROGNOSTIC ROLE OF TERT PROMOTER MUTATIONS IMPROVES THE STRATIFICATION OF IDH-MUTATED LOWER GRADE GLIOMA Neuro-Oncology. 21: vi151-vi151 |